AU526715B2 - Sulphonamide derivatives of phenylethanolamine - Google Patents
Sulphonamide derivatives of phenylethanolamineInfo
- Publication number
- AU526715B2 AU526715B2 AU40642/78A AU4064278A AU526715B2 AU 526715 B2 AU526715 B2 AU 526715B2 AU 40642/78 A AU40642/78 A AU 40642/78A AU 4064278 A AU4064278 A AU 4064278A AU 526715 B2 AU526715 B2 AU 526715B2
- Authority
- AU
- Australia
- Prior art keywords
- phenylethanolamine
- sulphonamide derivatives
- sulphonamide
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- ULSIYEODSMZIPX-UHFFFAOYSA-N alpha-hydroxyphenethylamine Natural products NCC(O)C1=CC=CC=C1 ULSIYEODSMZIPX-UHFFFAOYSA-N 0.000 title 1
- 229950006768 phenylethanolamine Drugs 0.000 title 1
- 150000003456 sulfonamides Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
USUS52-12203 | 1977-10-12 | ||
JP12203477A JPS5473751A (en) | 1977-10-12 | 1977-10-12 | Phenyl ethanolamine derivatives and their preparation |
JP12843677A JPS5463048A (en) | 1977-10-26 | 1977-10-26 | Novel phenyl ethanolamine derivatives and their preparation |
JPJP52-12843 | 1977-10-26 | ||
JP15535277A JPS5495544A (en) | 1977-12-23 | 1977-12-23 | Phenylethanolamine derivative and its preparation |
JP7496478A JPS552639A (en) | 1978-06-21 | 1978-06-21 | Phenylethanolamine derivative and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4064278A AU4064278A (en) | 1980-04-17 |
AU526715B2 true AU526715B2 (en) | 1983-01-27 |
Family
ID=27465764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU40642/78A Expired AU526715B2 (en) | 1977-10-12 | 1978-10-12 | Sulphonamide derivatives of phenylethanolamine |
Country Status (16)
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55124742A (en) * | 1979-03-20 | 1980-09-26 | Kyowa Hakko Kogyo Co Ltd | Novel aminoalcohol derivative |
US4206125A (en) * | 1979-05-04 | 1980-06-03 | Richardson-Merrell Inc. | 5-[2-[(2,3-Dihydro-1,4-benzodioxan-2-ylmethyl)amino]-1-hydroxyethyl]-2-hydroxybenzoic acid derivatives |
DD157796A5 (de) * | 1979-12-04 | 1982-12-08 | Ciba Geigy Ag | Verfahren zur herstellung neuer derivate des 2-amino-aethanols |
JPS56110665A (en) * | 1980-02-08 | 1981-09-01 | Yamanouchi Pharmaceut Co Ltd | Sulfamoyl-substituted phenetylamine derivative and its preparation |
US4558156A (en) * | 1980-02-08 | 1985-12-10 | Yamanouchi Pharmaceutical Co., Ltd. | Sulfamoyl-substituted phenethylamine derivatives |
US5391825A (en) * | 1980-02-08 | 1995-02-21 | Yamanouchi Pharmaceutical Co., Ltd. | Sulfamoyl substituted phenethylamine intermediates |
DE3128117A1 (de) * | 1980-07-29 | 1982-03-11 | Yamanouchi Pharmaceutical Co., Ltd., Tokyo | Neue phenyl-aethylaminderivate, verfahren zu ihrer herstellung |
CA1219865A (en) * | 1982-05-14 | 1987-03-31 | Leo Alig | Aziridine phenethanolamine derivatives |
PT78388B (en) * | 1983-04-12 | 1986-09-15 | Smithkline Beckman Corp | Dopamine-beta-hydroxylase inhibitors |
JPS6051106A (ja) * | 1983-08-31 | 1985-03-22 | Yamanouchi Pharmaceut Co Ltd | 塩酸アモスラロ−ル持続性製剤 |
EP0162404B1 (en) * | 1984-05-15 | 1988-08-24 | Seitetsu Kagaku Co., Ltd. | Process for preparing 2-alkyl-5-haloacetylbenzenesulfonamide |
US4678855A (en) * | 1985-10-09 | 1987-07-07 | Merck & Co., Inc. | Substituted benzenesulfonamides |
JPS62114952A (ja) * | 1985-11-13 | 1987-05-26 | Yamanouchi Pharmaceut Co Ltd | 置換フエネチルアミン誘導体の製造法 |
JPH0228141A (ja) * | 1987-11-13 | 1990-01-30 | Glaxo Group Ltd | フェネタノールアミン誘導体 |
EP0642789B1 (en) * | 1992-05-22 | 1999-09-29 | Senju Pharmaceutical Co., Ltd. | Remedy for glaucoma |
FR2737494B1 (fr) * | 1995-08-04 | 1997-08-29 | Synthelabo | Derives de benzenesulfonamide, leur preparation et leur application en therapeutique |
CA2242351C (en) * | 1996-01-10 | 2003-03-11 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel tricyclic compounds and drug compositions containing the same |
WO1999057131A1 (en) * | 1998-05-06 | 1999-11-11 | Duke University | Method of treating bladder and lower urinary tract syndromes |
FR2791675B1 (fr) * | 1999-03-30 | 2001-05-04 | Synthelabo | Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique |
US6835853B2 (en) * | 2001-10-31 | 2004-12-28 | Synthon Bv | Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith |
HRP20050163A2 (en) | 2002-08-19 | 2005-06-30 | Pfizer Products Inc. | Combination therapy for hyperproliferative diseases |
AU2004242777B2 (en) | 2003-05-30 | 2011-05-12 | Ranbaxy Laboratories Limited | Substituted pyrrole derivatives and their use as HMG-Co inhibitors |
KR100596373B1 (ko) | 2003-12-09 | 2006-07-04 | 씨제이 주식회사 | 광학적으로 순수한 펜에틸 아민 유도체의 제조방법 |
AP2007003979A0 (en) * | 2004-11-23 | 2007-06-30 | Warner Lambert Co | 7-(2h-pyrazol-3-yl)-3,5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for thetreatment of lipidemia |
CN100569745C (zh) * | 2005-05-27 | 2009-12-16 | 国际威林生化科技股份有限公司 | 制备坦舒乐欣的方法 |
GT200600381A (es) | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
BRPI0618379A2 (pt) | 2005-11-08 | 2011-08-30 | Ranbaxy Lab Ltd | processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
EP2026766A1 (en) | 2006-05-17 | 2009-02-25 | Synthon B.V. | Tablet composition with a prolonged release of tamsulosin |
US8404896B2 (en) | 2006-12-01 | 2013-03-26 | Bristol-Myers Squibb Company | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
US8465770B2 (en) * | 2008-12-24 | 2013-06-18 | Synthon Bv | Low dose controlled release tablet |
CN102050766B (zh) * | 2009-11-03 | 2013-08-07 | 安徽省新星药物开发有限责任公司 | 一种盐酸氨磺洛尔的合成方法 |
HK1213886A1 (zh) | 2013-04-17 | 2016-07-15 | 辉瑞大药厂 | 用於治療心血管疾病的n-哌啶-3-基苯甲酰胺衍生物 |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
MX2021008533A (es) | 2019-01-18 | 2021-08-19 | Astrazeneca Ab | Inhibidores de la pcsk9 y metodos de uso de los mismos. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3701808A (en) * | 1967-12-21 | 1972-10-31 | Allen & Hanburys Ltd | Phenylethanolamines |
GB1266058A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1969-07-08 | 1972-03-08 | ||
GB1321701A (en) | 1969-10-01 | 1973-06-27 | Continental Pharma | Amino-alcohols their salts and process for prepairing the same |
US3711545A (en) * | 1971-02-23 | 1973-01-16 | Smith Kline French Lab | Alpha-aminoalkyl-4-hydroxy-3-sulfamoylaminobenzyl alcohols |
DE2115926C3 (de) * | 1971-04-01 | 1978-05-03 | C.H. Boehringer Sohn, 6507 Ingelheim | 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel |
US4034112A (en) * | 1973-06-22 | 1977-07-05 | Imperial Chemical Industries Limited | Ethanolamine derivatives having β-adrenergic blocking activity |
US3860647A (en) * | 1973-08-20 | 1975-01-14 | Smithkline Corp | {60 -Aminomethyl-4-hydroxy-3-sulfamyl-benzyl alcohols and 4-hydroxy-3-sulfamyl phenethylamines |
GB1593651A (en) * | 1977-02-03 | 1981-07-22 | Allen & Hanburys Ltd | Amides |
DK31578A (da) * | 1977-02-03 | 1978-08-04 | Allen & Hanburys Ltd | Fremgangsmaade til fremstilling af benzenderivater |
-
1978
- 1978-09-22 CA CA000311934A patent/CA1147342A/en not_active Expired
- 1978-09-25 GR GR57301A patent/GR65337B/el unknown
- 1978-09-27 US US05/946,192 patent/US4217305A/en not_active Expired - Lifetime
- 1978-10-02 CH CH1021878A patent/CH639948A5/de not_active IP Right Cessation
- 1978-10-03 DE DE19782843016 patent/DE2843016A1/de active Granted
- 1978-10-06 PT PT68624A patent/PT68624A/pt unknown
- 1978-10-09 FR FR7828743A patent/FR2405931A1/fr active Granted
- 1978-10-11 AT AT0731778A patent/AT363457B/de not_active IP Right Cessation
- 1978-10-11 DK DK452178A patent/DK168484B1/da active
- 1978-10-11 IT IT69350/78A patent/IT1160853B/it active
- 1978-10-11 SE SE7810613A patent/SE448232B/sv not_active IP Right Cessation
- 1978-10-11 ES ES474149A patent/ES474149A1/es not_active Expired
- 1978-10-11 NO NO783442A patent/NO147148C/no unknown
- 1978-10-11 SU SU782673556A patent/SU982537A3/ru active
- 1978-10-12 AU AU40642/78A patent/AU526715B2/en not_active Expired
- 1978-10-12 GB GB7840390A patent/GB2006772B/en not_active Expired
-
1979
- 1979-06-13 ES ES481549A patent/ES481549A1/es not_active Expired
- 1979-10-18 SU SU792835396A patent/SU932982A3/ru active
Also Published As
Publication number | Publication date |
---|---|
AU4064278A (en) | 1980-04-17 |
ATA731778A (de) | 1981-01-15 |
FR2405931A1 (fr) | 1979-05-11 |
SE448232B (sv) | 1987-02-02 |
GB2006772B (en) | 1982-02-03 |
IT1160853B (it) | 1987-03-11 |
CH639948A5 (de) | 1983-12-15 |
GR65337B (en) | 1980-08-18 |
DK452178A (da) | 1979-04-13 |
NO783442L (no) | 1979-04-18 |
PT68624A (en) | 1978-11-01 |
IT7869350A0 (it) | 1978-10-11 |
ES481549A1 (es) | 1980-04-01 |
DE2843016C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1988-10-13 |
SU982537A3 (ru) | 1982-12-15 |
ES474149A1 (es) | 1979-10-16 |
NO147148C (no) | 1983-02-09 |
SU932982A3 (ru) | 1982-05-30 |
DK168484B1 (da) | 1994-04-05 |
NO147148B (no) | 1982-11-01 |
US4217305A (en) | 1980-08-12 |
SE7810613L (sv) | 1979-04-13 |
GB2006772A (en) | 1979-05-10 |
DE2843016A1 (de) | 1979-04-26 |
CA1147342A (en) | 1983-05-31 |
FR2405931B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1982-11-19 |
AT363457B (de) | 1981-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU526715B2 (en) | Sulphonamide derivatives of phenylethanolamine | |
AU519515B2 (en) | Preparation of nitrodiarylamines | |
AU519040B2 (en) | Preparation of nitrodiarylamines | |
AU2523477A (en) | Solutions of polyster-imides | |
AU519041B2 (en) | Preparation of nitrodiarylamines | |
AU517161B2 (en) | Alph-halomethyl derivatives of amines | |
IL53795A0 (en) | Derivatives of thio-methylcarbamates | |
AU531826B2 (en) | Sulphonamide derivatives | |
ZA783285B (en) | New derivatives of amidinopenicillanic acid | |
AU528071B2 (en) | Derivatives of fortimicin b | |
AU521750B2 (en) | Manufacture of polyalklenepolyamines | |
AU523488B2 (en) | Derivatives of sh-benzocyclohepten-7-amine and their salts | |
AU515729B2 (en) | N-formimidoylmethylaminothio sulfonamides | |
AU514875B2 (en) | 17-acetylene derivatives of androst-4-ene | |
GB2011393B (en) | Preparation of 1-hydroxyaphorphine derivatives | |
AU514563B2 (en) | Preparation of 2-hydroxybenzothiazole derivatives | |
AU519998B2 (en) | Benzenesulfonamide derivatives | |
AU517707B2 (en) | N-hydrazides of 2-benzo-thiazolinones | |
AU515561B2 (en) | Preparation of tetra-alkylthiuram disulphides | |
AU516387B2 (en) | Derivatives of oxanlic acid | |
AU512322B2 (en) | Derivatives of 2-phenyl-2-hydroxyethylamine | |
IL54308A0 (en) | Derivatives of 9-fluoroprednisolone | |
PT67667A (en) | New preparation of isobutyramide derivatives | |
AU518954B2 (en) | Derivatives of 9-chloroprednisolone | |
AU527083B2 (en) | Preparation of dihalocyclopropane derivatives |